CN109870433B - Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof - Google Patents

Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof Download PDF

Info

Publication number
CN109870433B
CN109870433B CN201711272434.7A CN201711272434A CN109870433B CN 109870433 B CN109870433 B CN 109870433B CN 201711272434 A CN201711272434 A CN 201711272434A CN 109870433 B CN109870433 B CN 109870433B
Authority
CN
China
Prior art keywords
probe
ganglioside
buoyancy
microsphere
cell surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201711272434.7A
Other languages
Chinese (zh)
Other versions
CN109870433A (en
Inventor
鞠熀先
陈云龙
刘惠普
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University
Original Assignee
Nanjing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University filed Critical Nanjing University
Priority to CN201711272434.7A priority Critical patent/CN109870433B/en
Publication of CN109870433A publication Critical patent/CN109870433A/en
Application granted granted Critical
Publication of CN109870433B publication Critical patent/CN109870433B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

The invention relates to a pair of buoyancy microsphere probes for quantitatively screening cell surface ganglioside and a preparation method thereof. The buoyant microsphere probe comprises an extraction probe and a collection probe. The extraction probe takes a silica buoyancy microsphere modified by maleimide as a substrate, and is covalently bonded with a DNA molecule with an endonuclease cutting site and a boric acid terminal. Through covalent recognition of boric acid and sialic acid on the cell surface, the extraction probe can extract biomolecules containing sialic acid on the cell surface through buoyancy. The extracted biomolecules can be released into the solution under the action of endonuclease, and the ganglioside with the nucleic acid fragments combined therein is collected by a collection probe silanized by octadecane through hydrophobic effect, and further fluorescence quantification is carried out on the ganglioside by using in vitro hybridization chain reaction.

Description

Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof
One, the technical field
The invention relates to a pair of buoyancy microsphere probes for quantitatively screening cell surface ganglioside and a preparation method thereof.
Second, background Art
Gangliosides are glycosphingolipids comprising one or more sialic acid terminal oligosaccharide chains. They are embedded in the cell membrane via the alkane chains of the ceramide portion, regulate cellular structure, cell adhesion and signal transduction, and serve as receptor sites for microbial toxins, bacteria and viruses. Gangliosides on the cell surface are continuously synthesized and degraded by corresponding highly specific enzymes in a way that increases or decreases the sugar units. Its aberrant glycosylation biological pathways are associated with diseases such as genetic diseases and malignant transformation of cancer. Abnormal overexpression of gangliosides of different subclasses is also strongly associated with the type and progression of tumors. Therefore, screening for gangliosides on the cell surface is of great importance to reveal their associated biological processes and potential tumor progression.
In order to realize quantitative detection of cell surface ganglioside, the patent prepares a pair of functionalized buoyancy microsphere probes, and realizes nondestructive quantitative screening of cell surface ganglioside.
Third, the invention
The purpose of the invention is: based on boric acid mediated covalent recognition of cell surface sialic acid and octadecyl molecule mediated hydrophobic interaction, extraction probes containing nucleic acid cleaving enzyme sites and boric acid terminals and collection probes containing octadecyl molecules were designed, respectively. The sialic acid containing biomolecules on the cell surface are non-destructively extracted using an extraction probe and the extract is released into solution by a nucleic acid cleaving enzyme. Then collecting lipid substance in the release, namely ganglioside, by using a collecting probe, and carrying out hybridization chain reaction through the nucleic acid fragment combined on the ganglioside to obtain a fluorescent signal for quantification. The MCF-7 breast cancer cell line is taken as a model, and the prepared probe realizes the quantification of the cell surface ganglioside.
The buoyant microsphere probe capable of quantitatively screening cell surface ganglioside provided by the invention is shown in figure 1. Using hydroxylated silica buoyancy microspheres as carriers, gradually carrying out amino silanization on the surfaces of the silica buoyancy microspheres, assembling a succinimide and maleimide double-modified polyethylene glycol connector, and further modifying functional DNA molecules with aminophenylboronic acid terminals and endonuclease sites to obtain extraction probes; and (3) directly carrying out octadecylsilylating on the hydroxylated silicon dioxide buoyancy microsphere to obtain the collecting probe.
The invention is realized by the following technical scheme:
1) the DNA molecule containing the endonuclease site is formed by hybridization of DNA1 and DNA 2. The 5' end of the DNA1 is modified with carboxyl for covalent coupling with aminophenylboronic acid; the 3' end is modified with sulfydryl and is used for being covalently connected to a maleamide group on the buoyant microsphere.
2) The extraction probe takes hydroxylated buoyancy microspheres as a carrier, amino silanization is firstly carried out, then a maleamide group is covalently modified, and finally DNA molecules containing endonuclease sites are covalently assembled; the collection probes were obtained by direct octadecylsilylation of hydroxylated buoyant microspheres as shown in figure 1.
The working principle of the invention is as follows:
the working principle of the invention is shown in figure 2: the extraction probes were first incubated with the cells on a vertical rotator and centrifuged intermittently. After several cycles, the extraction probes were separated from the cells by buoyancy under centrifugation. The extraction probe is then incubated with an endonuclease to cleave the extracted sialic acid group-containing biomolecule, along with the bound nucleic acid fragments, into solution. After removal of the extraction probe by buoyancy, a collection probe was added to the purge solution. After incubating for a period of time on a vertical rotation instrument, separating and collecting probes through buoyancy; and adding the initiation DNA of the hybrid chain reaction and a pair of hairpin DNAs into the collected probe dispersion liquid to perform hybrid chain reaction to obtain a fluorescent signal. And (3) obtaining a standard curve by using a standard ganglioside solution, and quantitatively detecting the cell surface ganglioside.
Compared with the prior art, the invention has the following characteristics:
the size of the buoyancy microsphere used in the invention is close to that of cells, and the buoyancy microsphere has the characteristics of rapid buoyancy separation capability and easy modification. The prepared extraction probe can efficiently and quickly act and separate with cells, and realizes the non-destructive extraction of the cell surface ganglioside. The prepared collecting probe can specifically collect the released ganglioside through hydrophobic interaction, and further obtains a sensitive fluorescent signal by utilizing hybridization chain reaction, thereby realizing the quantitative detection of the cell surface ganglioside.
Compared with the existing ganglioside detection method, the method has the following advantages:
1. the buoyancy microsphere probe is simple and convenient in preparation method and has high specific extraction capacity and collection capacity. The extraction process does not require cell disruption and other pretreatment steps, and is advantageous over prior methods.
2. The DNA functional molecule can efficiently release the captured biomolecule containing sialic acid group under the action of endonuclease. The nucleic acid fragments bound to gangliosides can trigger hybridization chain reactions, resulting in signal amplification.
Description of the drawings
FIG. 1 is a schematic diagram of the structure and synthesis of two buoyancy microsphere probes
FIG. 2 is a schematic diagram of the detection of cell surface ganglioside by two buoyant microsphere probes
Fifth, detailed description of the invention
Example 1: combining with figure 1, synthesizing buoyancy microsphere probe capable of quantitatively screening cell surface ganglioside
Disperse in hybridization buffer (TE +100mM NaCl and 10mM MgCl)2pH 8.0) of 100. mu.L of DNA1 (10. mu.M) and 100. mu.L of DNA2 (10. mu.M) were incubated at 37 ℃ with mixingAnd (4) at night. The resulting hybridization product was centrifuged with a 10Kd ultrafiltration tube and dispersed in phosphate buffer (PBS, pH 7.4). Then, 20. mu.L of aminobenzeneboronic acid (APBA, 500. mu.M) and 20. mu.L of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide (EDC, 500. mu.M) were added thereto, respectively, and stirred at room temperature overnight. The resulting functional DNA molecule (HS-DNA1/2-APBA) was centrifuged with a 10Kd ultrafiltration centrifuge tube and dispersed in TE buffer for further use.
Silica buoyant microspheres (about 2.5X 10)7One) was first stirred overnight with piranha (30% hydrogen peroxide: 98% sulfuric acid 1: 3) on a vertical rotary stirrer. The obtained hydroxylated buoyancy microspheres are washed and dried, and then stirred overnight with 1mL of 5% amino silanization reagent dissolved in methanol. The obtained amino silanized buoyant microspheres were washed twice with methanol and Dimethylformamide (DMF), dispersed into a DMF solution containing succinimide and maleimide di-modified polyethylene glycol (NHS-PEG-Mal, 100mM) and N, N-diisopropylethylamine (DIPEA, 150mM), stirred overnight at room temperature, and then washed twice with DMF and water. And finally, adding 100 mu L of 1 mu M HS-DNA1/2-APBA into the obtained buoyancy microsphere modified with maleimide groups, stirring overnight at room temperature, and washing twice with water to obtain the extraction probe.
Hydroxylated silica buoyant microspheres (about 1.5X 10)6One) was added to a methanol solution containing 5% octadecylsilane reagent, stirred overnight at room temperature, and washed twice with methanol and PBS to obtain a collection probe.
Example 2: with reference to FIG. 2, quantitative determination of gangliosides on cell surface was performed using a buoyant microsphere probe
MCF-7 cells (50. mu.L, 1.2X 10) were used as a basic model for MCF-7 breast cancer cell lines5mL-1) And extraction probe (50. mu.L, 9.6X 10)5mL-1) After mixing and shaking in PBS solution for 55 minutes, it was centrifuged at 1000rpm for 5 minutes. After 4 cycles, centrifugation was performed, and the floated extraction probe was taken out by buoyancy, washed twice with PBS, and added to 100. mu.L of an enzyme digestion buffer containing 2% Eco47 III. Stirring, incubating for 15 min, centrifuging, removing floating extraction probe by buoyancy, adding into the lower solution10 μ L of collection probe (9X 10)4mL-1) After incubation for two hours at room temperature with stirring, the cells were centrifuged and washed twice with PBS. The resulting collected ganglioside-collected collection probe was added to 100. mu.L of hybridization buffer containing hybridization chain reaction primer (1. mu.M), hybridization chain reaction hairpin H1 (10. mu.M) and H2 (10. mu.M), and mixed and incubated at 37 ℃ for 4 hours. The resulting collection probe was centrifuged, washed twice with TE, and fluorescence imaged to obtain a quantitative fluorescent signal.
Standard solutions of ganglioside GD1a at different concentrations (50. mu.L, 0.5, 1.0, 1.5, 2.0, 2.5nM) were mixed with extraction probes (50. mu.L, 9.6X 10, respectively)5mL-1) And (3) incubating in a PBS solution, performing enzyme digestion, collection and hybridization chain reaction by using the same method to obtain a standard curve, and combining a fluorescence signal of a cell experiment to obtain a quantitative detection result of the cell surface ganglioside.

Claims (3)

1. A buoyancy microsphere probe for quantitatively screening cell surface ganglioside is characterized by comprising an extraction probe and a collection probe; the extraction probe takes silicon dioxide buoyancy microspheres as a carrier and respectively loads functional DNA molecules with endonuclease Eco47III cutting sites and boric acid terminals; the functional DNA molecule is formed by hybridizing DNA1 and DNA2, the 3' end of the DNA1 is sulfydryl, and the DNA molecule is connected to the carbon dioxide buoyancy microsphere subjected to amino silanization through a succinimide and maleimide double-modified polyethylene glycol chain; the 5' end of the DNA1 is carboxyl, and is used for specifically identifying and extracting biomolecules containing sialic acid groups on the cell surface by covalently bonding aminophenylboronic acid molecules; the DNA2 is hybridized with the middle part of the DNA1 to form a cutting site of an endonuclease Eco47 III; the extraction probe can rapidly act on and separate from cells, so that the non-destructive extraction of the cell surface ganglioside is realized; the collecting probe is obtained by directly performing octadecyl silanization on the hydroxylated silicon dioxide buoyancy microsphere, the collecting probe performs specific collection on the released ganglioside through hydrophobic effect, and a fluorescence signal is further obtained by utilizing a hybrid chain reaction, so that quantitative detection of the cell surface ganglioside is realized.
2. The buoyant microsphere probe of claim 1, wherein the collected sialic acid group containing biomolecules on the surface of the extraction probe are cleaved with the endonuclease Eco47III and released into solution along with the bound nucleic acid fragments, and the ganglioside containing molecules in the release are collected by the collection probe.
3. The buoyant microsphere probe of claim 1, wherein the ganglioside-containing molecules collected on the surface of the collection probe can hybridize with the priming sequence via the nucleic acid fragments bound thereto, and initiate a hybridization chain reaction to obtain a fluorescent signal.
CN201711272434.7A 2017-12-01 2017-12-01 Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof Active CN109870433B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711272434.7A CN109870433B (en) 2017-12-01 2017-12-01 Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711272434.7A CN109870433B (en) 2017-12-01 2017-12-01 Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof

Publications (2)

Publication Number Publication Date
CN109870433A CN109870433A (en) 2019-06-11
CN109870433B true CN109870433B (en) 2021-06-15

Family

ID=66915233

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711272434.7A Active CN109870433B (en) 2017-12-01 2017-12-01 Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109870433B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115960160A (en) * 2021-10-12 2023-04-14 南京大学 Live cell membrane integrin alpha v β 3 Method for in situ sugar chain extension of glycans

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099407A1 (en) * 2003-05-09 2004-11-18 Chemical Biology Institute Method of testing sensitivity to anticancer drug
CN1553188A (en) * 2003-06-06 2004-12-08 克 宋 Microarray signal amplifying method
CN1914335A (en) * 2004-02-06 2007-02-14 Isis药物公司 Antisense oligonucleotide modulation of STAT3 expression
EP2026067A1 (en) * 2006-05-30 2009-02-18 Japan Science and Technology Agency Method for detection of disease having insulin-resistant condition
WO2011126126A1 (en) * 2010-04-06 2011-10-13 住友化学株式会社 NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF
CN103418295A (en) * 2007-06-21 2013-12-04 简.探针公司 Appratus and means for contents of mixing detection receptacle
CN105378450A (en) * 2013-02-18 2016-03-02 赛拉诺斯股份有限公司 Systems and methods for multi-analysis
CN206450638U (en) * 2016-09-30 2017-08-29 珠海赛隆药业股份有限公司 The GM1 detection chromatographic column of high-purity

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099407A1 (en) * 2003-05-09 2004-11-18 Chemical Biology Institute Method of testing sensitivity to anticancer drug
CN1553188A (en) * 2003-06-06 2004-12-08 克 宋 Microarray signal amplifying method
CN1914335A (en) * 2004-02-06 2007-02-14 Isis药物公司 Antisense oligonucleotide modulation of STAT3 expression
EP2026067A1 (en) * 2006-05-30 2009-02-18 Japan Science and Technology Agency Method for detection of disease having insulin-resistant condition
CN103418295A (en) * 2007-06-21 2013-12-04 简.探针公司 Appratus and means for contents of mixing detection receptacle
WO2011126126A1 (en) * 2010-04-06 2011-10-13 住友化学株式会社 NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF
CN105378450A (en) * 2013-02-18 2016-03-02 赛拉诺斯股份有限公司 Systems and methods for multi-analysis
CN206450638U (en) * 2016-09-30 2017-08-29 珠海赛隆药业股份有限公司 The GM1 detection chromatographic column of high-purity

Also Published As

Publication number Publication date
CN109870433A (en) 2019-06-11

Similar Documents

Publication Publication Date Title
Wan et al. Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes
Kang et al. High-purity capture and release of circulating exosomes using an exosome-specific dual-patterned immunofiltration (ExoDIF) device
Mohammadi et al. Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis
US20130123121A1 (en) Methods and/or Use of Oligonucleotide-Bead Conjugates for Assays and Detections
US20130344508A1 (en) Methods and/or Use of Oligonucleotide Conjugates for Suppressing Background Due to Cross-Hybridization
JPWO2015045666A1 (en) Fluid device, exosome analysis method, biomolecule analysis method, and biomolecule detection method
WO2018090651A1 (en) Method for pretreating protein in ex vivo body fluid
US20180105778A1 (en) Multi-stage purification method and apparatus of extracellular vesicles using aqueous solution two-phase system
CN102658098A (en) Boron affine functionalization material, preparation and application with adjacent hydroxyl methyl benzene boric acid serving as functional monomer
US20190276820A1 (en) Single extracellular vesicle multiplexed protein and rna analysis
CN109870433B (en) Buoyancy microsphere probe for quantitative screening of ganglioside and preparation method thereof
EP1373573A4 (en) Conjugate probes and optical detection of analytes
Miranda-Castro et al. The translational potential of electrochemical DNA-based liquid biopsy
CN111073846A (en) Method for separating extracellular vesicles from tissue specific sources and kit thereof
Pallares-Rusiñol et al. Advances in exosome analysis
CN109553797A (en) A kind of preparation and its Application in Sensing of functionalization three-dimensional graphene composite material
KR20200054268A (en) Detection of recombinase polymerase amplification using a double-hapten probe
JP2023100770A (en) Manufacturing device and manufacturing method for exosome liquid biopsy sample
US20210379591A1 (en) Fragmentation of target molecules for sequencing
Chen et al. Quantitative Screening of Cell‐Surface Gangliosides by Nondestructive Extraction and Hydrophobic Collection
CN101470111B (en) Preparation and use of novel nano-Au composite substrate NCS
CN107976548A (en) Detection fibrin ferment kit based on tetra- serobilas of micro-fluidic chip and G--ferroheme DNA enzymatic and its preparation method and application
US8975017B2 (en) Process for concentrating nucleic acid molecules
CN104177451A (en) Non-natural difunctional saccharides, and preparing methods and applications thereof
CA3177368A1 (en) Devices and methods for sequencing

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant